Nvidia Interim CEO Colette Kress: “We’ve got this.” She’s Right. Q3 Earnings Wrap
Nvidia reported $115.8 billion in Q3 revenue, up 103%, and raised its fiscal 2028 growth outlook to 75% as interim CEO Colette Kress reaffirmed its AI roadmap.
Nvidia reported $115.8 billion in Q3 revenue, up 103%, and raised its fiscal 2028 growth outlook to 75% as interim CEO Colette Kress reaffirmed its AI roadmap.
@akramsrazor Ultimately, over a 2 to 3 year window, there are: too many GPU/ASIC-TPU suppliers; demand is not sustainable; and there is too much price competition (in the form of loans, gaurantees, and warrants) = thus, they’re all shorts $AMD $AVGO $NVDA
Doesn’t seem like this story is going to die easily. How long until $NVDA’s GC is running the show?
To be honest though, I have successfully short $COST twice in the past, it’s just terribly low beta so even if you time it right it’s a slow trade
CNBC headline: "Nvidia interim CEO Kress talks exclusively to CNBC’s Jim Cramer". Oh no. $NVDA
CDW CEO Chris Leahy says AI adoption has reached a make-or-break phase as customers seek trusted guidance amid proliferating IT choices.
Realty Income trades near $58, with 2026 AFFO guidance of $4.45 to $4.46 per share and a 5.5% dividend yield supported by a low-70% payout…
Alphabet’s Google Cloud, Gemini training costs and capex shape the company’s valuation as cloud becomes a larger earnings driver.
S&P Global’s valuation swung from 7x earnings in 2009 to 50x in 2024 as ratings, indices and proprietary data expanded through acquisitions…
Amneal Pharmaceuticals posted its fourth straight earnings beat, with Q3 revenue up 10%, raised FY26 guidance and an expanding biosimilar…
Monte Investments rotated Nvidia into Alphabet before earnings and reviews Knife River’s margin squeeze, AMD’s World Labs acquisition, and…
Elanco’s earnings inflection and prospective dividend support targeted low-double-digit EPS growth despite Zoetis discounting.
Bruce Flatt’s Brookfield built 19 percent annual returns by buying distressed real assets below replacement cost with long-term…
Forestar trades near $22 versus $37.56 in tangible book value, with $657 million of cash and a potential D.R.
Entravision’s AdTech revenue rose 133% and EBIT 261% in Q3 as management weighs TV-station sales before its TelevisaUnivision agreement…
KRYS · short Krystal Biotech is a profitable commercial-stage biotech with an $8.7 billion enterprise value and one FDA-approved topical gene therapy,…
RIN prices near all-time highs reflect tighter renewable-fuel mandates, a shrinking credit bank, and biodiesel production shortfalls.
AutoZone held an estimated 6.7% share of the $29.9 billion ex-tire auto parts market in 1996, leaving a long consolidation runway in a…
United Parks trades at 8x EBITDA with an 8%+ unlevered cash yield, aggressive buybacks and roughly 80% effective short interest, while…
Meta’s planned cloud business and Moonshot AI’s Kimi K3 revived doubts over AI compute scarcity, driving chip stocks lower and exposing S&P…
Boston Scientific built its interventional-medicine portfolio through acquisitions, but early-2000s growth became heavily dependent on the…
Braemar’s BHR-PB preferred trades near $13 against a $25 liquidation preference, yielding 10% amid hotel sales, a $480 million Ashford…
On Holdings expects roughly CHF 3.5 billion in FY26 revenue as running shoes drive growth, while APAC exceeds 20% of sales and apparel…
The Black Patch Tobacco Wars show how American Tobacco’s buying power drove Kentucky and Tennessee farmers to organize against below-cost…
Semiconductor optical amplifiers offer compact, low-cost gain for LiDAR, long-haul links and ultra-high-power co-packaged optics, trading…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.